Skip to main content
. 2011 Oct;179(4):1827–1838. doi: 10.1016/j.ajpath.2011.06.032

Table 2.

Relationship between Twist1 Expression of 195 Gastric Cancers and Various Clinicopathologic Factors

Characteristic Total Twist1 expression in cancer cells
Twist1 expression in cancer associated fibroblasts
Negative, no. (%) Positive, no. (%) P value Negative, no. (%) Positive, no. (%) P value
Age, years
 <60 87 62 (71.3) 25 (28.7) 0.891 24 (27.6) 63 (72.4) 0.794
 ≥60 108 76 (70.1) 32 (29.6) 28 (25.9) 80 (74.1)
Sex
 Female 122 86 (70.5) 36 (29.5) 0.912 30 (24.6) 92 (75.4) 0.397
 Male 73 52 (71.2) 21 (28.8) 22 (30.1) 51 (69.9)
Size, cm
 <5 86 70 (81.4) 16 (18.6) 0.004 34 (39.5) 52 (60.5) <0.001
 ≥5 109 68 (62.4) 41 (37.6) 18 (16.5) 91 (83.5)
Differentiation
 WD 37 34 (91.9) 3 (8.1) 0.007 12 (32.4) 25 (67.6) 0.263
 MD 63 42 (66.7) 21 (33.3) 15 (23.8) 48 (76.2)
 PD 63 38 (60.3) 25 (39.7) 13 (20.6) 50 (79.4)
 Other types 32 24 (75.0) 8 (25.0) 12 (37.5) 20 (62.5)
Lauren classification
 Intestine 100 76 (76.0)) 24 (24.0) 0.099 26 (26.0) 74 (74.0) 0.829
 Mixed or diffuse 95 62 (65.3) 33 (34.7) 26 (27.4) 69 (72.6)
pT classification
 T1-T2 90 67 (74.4) 23 (25.6) 0.296 34 (37.8) 56 (62.2) 0.001
 T3-T4 105 71 (67.6) 34 (33.4) 18 (17.1) 87 (82.9)
Lymph node metastasis
 Negative 71 60 (84.5) 11 (15.5) 0.001 32 (45.1) 39 (54.9) <0.001
 Positive 124 78 (62.9) 46 (37.1) 20 (16.1) 104 (83.9)

MD, moderately differentiated; PD, poorly differentiated; WD, well differentiated.

Other types included signet ring cell carcinoma and mucinous carcinoma.